With a new US$5 million fundraising, a medical technology offshoot from Nanyang Technological University (NTU) Singapore hopes to increase the availability of its rehabilitation services in the US.

The startup, named Synphne, seeks to enhance the management of neurological disorders and strokes.

Related Cala Health's Neurostimulation System Treats Parkinson's

The company's main offering is a wearable gadget that helps those recovering from brain injuries and diseases like strokes. It intends to target markets such as Singapore and India in addition to the US.

HOW IT WORKS

The platform measures an individual's brain and muscle activity, which are also shown in near real-time to their therapists through in-person sessions or remotely guided tele-sessions. This data will allow them to personalize the patient's therapy by appropriate difficulty level, speed, and duration.

SynPhNe can also help enhance cognition and balance for some brain-muscle dysfunctions by mimicking how babies learn. Additionally, it can potentially improve hand function by up to 70% within 6-8 weeks and train children with learning difficulties to improve reading, comprehension, and writing within eight weeks, reports MobiHealthNews.

An affiliate of the Nadathur Group, Event Horizon Technologies, is one of the company's investors in the series A round. Nadathur Raghavan, a co-founder of Infosys, a consulting and digital services company, runs the organization as his family office.

The National Research Foundation, the National Medical Research Council, and the Singapore-MIT Alliance for Research and Technology are just a few of the Singaporean research and enterprise initiatives that have supported Synphne since it was first established under the NTUitive program.